After an experimental treatment for Hep C nearly kills him, Wes quits NorBAC to enroll in a revolutionary HCV program in Stockholm. A racist city councilor claims his daughter was poisoned by Muslim extremists. The FDA is willing to expedite some drugs to save an immune-deficient woman infected with smallpox.

A pharmaceutical company comes under fire when its newly-marketed immune suppressing drug triggers a high incidence of congestive heart failure. David must find a replacement for Wes. Bob recalls romantic memories of a girl named Nina after suffering a stroke.